AMG
ABBV icon

Asset Management Group’s AbbVie ABBV Stock Holding History

Asset Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,420
Closed -$562K – 111
2019
Q3 		$562K Sell
7,420
-2,613
-26% -$179K 0.19% 80
2019
Q2 		$730K Buy
10,033
+41
+0.4% +$3.22K 0.26% 71
2019
Q1 		$805K Buy
9,992
+16
+0.2% +$1.31K 0.29% 68
2018
Q4 		$920K Buy
9,976
+12
+0.1% +$1.05K 0.38% 62
2018
Q3 		$942K Buy
9,964
+12
+0.1% +$1.14K 0.32% 67
2018
Q2 		$922K Buy
9,952
+10
+0.1% +$977 0.32% 69
2018
Q1 		$941K Buy
9,942
+7
+0.1% +$769 0.34% 62
2017
Q4 		$961K Buy
9,935
+8
+0.1% +$754 0.35% 65
2017
Q3 		$882K Sell
9,927
-656
-6% -$49.9K 0.33% 66
2017
Q2 		$767K Buy
10,583
+14
+0.1% +$941 0.3% 71
2017
Q1 		$689K Buy
10,569
+15
+0.1% +$943 0.27% 71
2016
Q4 		$661K Buy
10,554
+12
+0.1% +$732 0.27% 70
2016
Q3 		$665K Buy
10,542
+12
+0.1% +$777 0.28% 72
2016
Q2 		$652K Buy
10,530
+13
+0.1% +$792 0.28% 72
2016
Q1 		$601K Buy
10,517
+15
+0.1% +$836 0.27% 74
2015
Q4 		$622K Buy
10,502
+11
+0.1% +$634 0.28% 73
2015
Q3 		$571K Buy
10,491
+10
+0.1% +$651 0.27% 73
2015
Q2 		$704K Sell
10,481
-108
-1% -$7.05K 0.32% 68
2015
Q1 		$620K Buy
10,589
+11
+0.1% +$665 0.29% 69
2014
Q4 		$692K Buy
10,578
+8
+0.1% +$504 0.35% 59
2014
Q3 		$611K Buy
10,570
+124
+1% +$6.88K 0.33% 59
2014
Q2 		$590K Buy
10,446
+6
+0.1% +$315 0.32% 58
2014
Q1 		$537K Hold
10,440
– – 0.31% 59
2013
Q4 		$551K Hold
10,440
– – 0.34% 52
2013
Q3 		$467K Hold
10,440
– – 0.3% 53
2013
Q2 		$432K Buy
+10,440
New +$457K 0.3% 52

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Asset Management Group's ABBV Position: Q4 2019 in Review

Asset Management Group sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 7,420 shares — an estimated $562K sold.

Asset Management Group first reported a position in ABBV in Q2 2013 and held it in 26 quarters. The position peaked at $961K in Q4 2017. 2,244 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Asset Management Group reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • Asset Management Group sold 7,420 AbbVie shares in Q4 2019, an estimated $562K.
  • Asset Management Group first reported a position in AbbVie in Q2 2013 and held it in 26 quarters.
  • Asset Management Group's AbbVie position peaked at $961K in Q4 2017.
  • 2,244 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Asset Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.